RNA-mediated neuromuscular disorders

Annual Review of Neuroscience

Volumn 29, Issue , 2006, Pages 259-277

  Ranum, Laura P W ^a   Cooper, Thomas A ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Fragile X tremor ataxia syndrome; Huntington's disease like 2; Myotonic dystrophy; Spinocerebellar ataxia

Indexed keywords

MYOTONIC DYSTROPHY PROTEIN KINASE; RNA; RNA BINDING PROTEIN;

3' UNTRANSLATED REGION; ATAXIA; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; HUNTINGTON DISEASE LIKE 2; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 1; MYOTONIC DYSTROPHY TYPE 2; NEUROMUSCULAR DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RNA PROCESSING; RNA SPLICING; SPINOCEREBELLAR ATAXIA TYPE 10; SPINOCEREBELLAR ATAXIA TYPE 12; SPINOCEREBELLAR ATAXIA TYPE 8; TREMOR; ANIMAL; CLASSIFICATION; DOMINANT GENE; GENETICS; METABOLISM; SPINOCEREBELLAR DEGENERATION; TRINUCLEOTIDE REPEAT;

ANIMALS; GENES, DOMINANT; HUMANS; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASES; RNA; RNA-BINDING PROTEINS; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 33748373580     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.neuro.29.051605.113014     Document Type: Review

References (91)

1. Anant S, Henderson JO, Mukhopadhyay D, Navaratnam N, Kennedy S, et al. 2001. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor. J. Biol. Chem. 276:47338-51
2. Berul CI, Maguire CT, Gehrmann J, Reddy S. 2000. Progressive atrioventricular conduction block in a mouse myotonic dystrophy model. J. Interv. Card. Electrophysiol. 4:351-58
3. Bidichandani SI, Ashizawa T, Patel PI. 1998. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am. J. Hum. Genet. 62:111-21
4. Black DL. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72:291-336
5. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, et al. 1992. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799-808
6. Buj-Bello A, Furling D, Tronchere H, Laporte J, Lerouge T, et al. 2002. Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. Hum. Mol. Genet. 11:2297-307
7. Cellini E, Nacmias B, Forleo P, Piacentini S, Guarnieri BM, et al. 2001. Genetic and clinical analysis of spinocerebellar ataxia type 8 repeat expansion in Italy. Arch. Neurol. 58:1856-59
8. Charlet BN, Logan P, Singh G, Cooper TA. 2002. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol. Cell 9:649-58
9. Cho DH, Thienes CP, Mahoney SE, Analau E, Filippova GN, Tapscott SJ. 2005. Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol. Cell 20:483-89
10. Dansithong W, Paul S, Comai L, Reddy S. 2005. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J. Biol. Chem. 280:5773-80
11. Davis BM, McCurrach ME, Taneja KL, Singer RH, Housman DE. 1997. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. USA 94:7388-93
12. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, et al. 2003. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60:657-64
13. Day JW, Schut LJ, Moseley ML, Durand AC, Ranum LPW. 2000. Spinocerebellar ataxia type 8: clinical features in a large family. Neurology 55:649-57
14. Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, et al. 2002. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet. 11:805-14
15. Faustino NA, Cooper TA. 2003. Pre-mRNA splicing and human disease. Genes Dev. 17:419-37
16. Filippova GN, Thienes CP, Penn BH, Cho DH, Hu YJ, et al. 2001. CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus. Nat. Genet. 28:335-43
17. Fu YH, Pizzuti A, Fenwick RGJr, King J, Rajnarayan S, et al. 1992. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256-58
18. Groenen P, Wieringa B. 1998. Expanding complexity in myotonic dystrophy. Bioessays 20:901-12
19. Hagerman PJ, Hagerman RJ. 2004. The fragile-X premutation: a maturing perspective. Am. J. Hum. Genet. 74:805-16
20. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, et al. 2001. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57:127-30
21. Harper PS. 2001. Myotonic Dystrophy. London: W.B. Saunders
22. Ho TH, Bundman D, Armstrong DL, Cooper TA. 2005a. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum. Mol. Genet. 14:1539-47
23. Ho TH, Charlet BN, Poulos MG, Singh G, Swanson MS, Cooper TA. 2004. Muscleblind proteins regulate alternative splicing. EMBO J. 23:3103-12
24. Ho TH, Savkur RS, Poulos MG, Mancini MA, Swanson MS, Cooper TA. 2005b. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J. Cell. Sci. 118:2923-33
25. Holmes SE, Hearn EO, Ross CA, Margolis RL. 2001a. SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia. Brain Res. Bull. 56:397-403
26. Holmes SE, O'Hearn E, Margolis RL. 2003. Why is SCA12 different from other SCAs? Cytogenet. Genome Res. 100:189-97
27. Holmes SE, O'Hearn E, Rosenblatt A, Callahan C, Hwang HS, et al. 2001b. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat. Genet. 29:377-78
28. Holmes SE, O'Hearn EE, Mclnnis MG, Gorelick-Feldman DA, Kleiderlein JJ, et al. 1999. Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12. Nat. Genet 23:391-92
29. Ikeda Y, Shizuka M, Watanabe M, Okamoto K, Shoji M. 2000. Molecular and clinical analyses of spinocerebellar ataxia type 8 in Japan. Neurology 54:950-55
30. Int. Hum. Genome Sequation Consort. 2004. Finishing the euchromatic sequence of the human genome. Nature 431:931-45
31. Iwahashi CK, Yasui DH, An HJ, Greco CM, Tassone F, et al. 2005. Protein composition of the intranuclear inclusions of FXTAS. Brain 129:256-71
32. Jiang H, Mankodi A, Swanson M, Thornton C. 2004a. Molecular pathogenesis of myotonic dystrophy in brain. Presented at 4th Int. Conf. Hum. Microsatell. Hum. Dis., Alberta, Canada
33. Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA. 2004b. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet. 13:3079-88
34. Jin P, Zarnescu DC, Zhang F, Pearson CE, Lucchesi JC, et al. 2003. RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39:739-47
35. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, et al. 2003. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302:2141-44
36. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, et al. 2003. A muscleblind knockout model for myotonic dystrophy. Science 302:1978-80
37. 2+-ATPase in myotonic dystrophy type 1. Hum. Mol. Genet. 14:2189-200
38. Klesert TR, Cho DH, Clark JI, Maylie J, Adelman J, et al. 2000. Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy. Nat. Genet. 25:105-9
39. Koob MD, Benzow KA, Bird TD, Day JW, Moseley ML, Ranum LPW. 1998. Rapid cloning of expanded trinucleotide repeat sequences from genomic DNA. Nat. Genet. 18:72-75
40. Koob MD, Moseley ML, Schut LJ, Benzow KA, Bird TD, et al. 1999. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat. Genet. 21:379-84
41. Ladd AN, Charlet N, Cooper TA. 2001. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol. 21:1285-96
42. Ladd AN, Stenberg MG, Swanson MS, Cooper TA. 2005. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev. Dyn. 233:783-93
43. Lewis BP, Green RE, Brenner SE. 2003. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. USA 100:189-92
44. Lin X, Ashizawa T. 2003. SCA10 and ATTCT repeat expansion: clinical features and molecular aspects. Cytogenet. Genome Res. 100:184-88
45. Lin X, Ashizawa T. 2005. Recent progress in spinocerebellar ataxia type-10 (SCA10). Cerebrum 4:37-42
46. Liquori C, Ricker K, Moseley ML, Jacobsen JF, Kress W, et al. 2001. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864-67
47. Mankodi A, Logigian E, Callahan L, McClain C, White R, et al. 2000. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289:1769-73
48. Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, et al. 2002. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10:35-44
49. Mankodi A, Teng-Umnuay P, Krym M, Henderson D, Swanson M, Thornton CA. 2003. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann. Neurol. 54:760-68
50. Margolis RL, Rudnicki DD, Holmes SE. 2005. Huntington's disease like-2: review and update. Acta Neurol. Taiwan 14:1-8
51. Martins S, Seixas AI, Magalhaes P, Coutinho P, Sequeiros J, Silveira I. 2005. Haplotype diversity and somatic instability in normal and expanded SCA8 alleles. Am. J. Med. Genet. B Neuropsychiatr. Genet. 139:109-14
52. Marz P, Probst A, Lang S, Schwager M, Rose-John S, et al. 2004. Ataxin-10, the spinocerebellar ataxia type 10 neurodegenerative disorder protein, is essential for survival of cerebellar neurons. J. Biol. Chem. 279:35542-50
53. Matsuura T, Yamagata T, Burgess DL, Rasmussen A, Grewal RP, et al. 2000. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat. Genet. 26:191-94
54. Meola G, Moxley RT III. 2004. Myotonic dystrophy type 2 and related myotonic disorders. J. Neurol. 251:1173-82
55. Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, et al. 2000. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19:4439-48
56. Modrek B, Resch A, Grasso C, Lee C. 2001. Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucl. Acids Res. 29:2850-59
57. Moseley ML, Schut LJ, Bird TD, Koob MD, Day JW, Ranum LPW. 2000. SCA8 CTG repeat: en masse contractions in sperm and intergenerational sequence changes may play a role in reduced penetrance. Hum. Mol. Genet. 9:2125-30
58. Moseley ML, Weatherspoon M, Rasmussen L, Day JW, Ranum LPW. 2002. SCA8 BAC transgenic mice have a progressive and lethal neurological phenotype demonstrating pathogenicity of the CTG expansion. Am. J. Hum. Genet. Suppl. 71:176
59. Moxley RT III, Griggs RC, Goldblatt D, VanGelder V, Herr BE, Thiel R. 1978. Decreased insulin sensitivity of forearm muscle in myotonic dystrophy. J. Clin. Invest. 62:857-67
60. Mukhopadhyay D, Houchen CW, Kennedy S, Dieckgraefe BK, Anant S. 2003. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol. Cell 11:113-26
61. Mutsuddi M, Marshall C, Benzow K, Koob M, Rebay I. 2004. The spinocerebellar ataxia 8 noncoding RNA causes neurodegeneration and associates with staufen in Drosophila. Curr. Biol. 14:302-8
62. Napierala M, Krzyzosiak WJ. 1997. CUG repeats present in myotonin kinase RNA form metastable "slippery" hairpins. J. Biol. Chem. 272:31079-85
63. O'Hearn E, Holmes SE, Calvert PC, Ross CA, Margolis RL. 2001. SCA-12: tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion. Neurology 56:299-303
64. Oostra BA, Willemsen R. 2003. A fragile balance: FMR1 expression levels. Hum. Mol. Genet. 12:R249-57
65. Paillard L, Omilli F, Legagneux V, Bassez T, Maniey D, Osborne HB. 1998. EDEN and EDEN-BP, a cis element and an associated factor that mediate sequence-specific mRNA deadenylation in Xenopus embryos. EMBO J. 17:278-87
66. Philips AV, Timchenko LT, Cooper TA. 1998. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280:737-41
67. Ranum LP, Day JW. 2004. Myotonic dystrophy: RNA pathogenesis comes into focus. Am. J. Hum. Genet. 74:793-804
68. Rasmussen A, Matsuura T, Ruano L, Yescas P, Ochoa A, et al. 2001. Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann. Neurol. 50:234-39
69. Reddy S, Smith DB, Rich MM, Leferovich JM, Reilly P, et al. 1996. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat. Genet. 13:325-35
70. Redman JB, Fenwick RG Jr, Fu YH, Pizzuti A, Caskey CT. 1993. Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. JAMA 269:1960-65
71. Ricker K, Koch MC, Lehmann-Horn F, Pongratz D, Otto M, et al. 1994. Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 44:1448-52
72. Roberts R, Timchenko NA, Miller JW, Reddy S, Caskey CT, et al. 1997. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc. Natl. Acad. Sci. USA 94:13221-26
73. Sarkar PS, Appukuttan B, Han J, Ito Y, Ai C, et al. 2000. Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts. Nat. Genet. 25:110-14
74. Savkur RS, Philips AV, Cooper TA. 2001. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29:40-47
75. Savkur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, et al. 2004. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am. J. Hum. Genet. 74:1309-13
76. Sergeant N, Sablonniere B, Schraen-Maschke S, Ghestem A, Maurage CA, et al. 2001. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 10:2143-55
77. Seznec H, Agbulut O, Sergeant N, Savouret C, Ghestem A, et al. 2001. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum. Mol. Genet. 10:2717-726
78. Shyu AB, Wilkinson MF. 2000. The double lives of shuttling mRNA binding proteins. Cell 102:135-38
79. Sowell ER, Levitt J, Thompson PM, Holmes CJ, Blanton RE, et al. 2000. Brain abnormalities in early-onset schizophrenia spectrum disorder observed with statistical parametric mapping of structural magnetic resonance images. Am. J. Psychiatry 157:1475-84
80. Steinbach P, Glaser D, Vogel W, Wolf M, Schwemmle S. 1998. The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat. Am. J. Hum. Genet. 62:278-85
81. Stevanin G, Herman A, Durr A, Jodice C, Frontali M, et al. 2000. Are (CTG)n expansions at the SCA8 locus rare polymorphisms? Nat. Genet. 24:213
82. Tapscott SJ, Thornton CA. 2001. Reconstructing myotonic dystrophy. Science 293:816-17
83. Tassone F, Hagerman RJ, Garcia-Arocena D, Khandjian EW, Greco CM, Hagerman PJ. 2004. Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J. Med. Genet. 41:e43
84. Thornton CA, Griggs RC, Moxley RT. 1994. Myotonic dystrophy with no trinucleotide repeat expansion. Ann. Neurol. 35:269-72
85. Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, et al. 1996. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 24:4407-14
86. Timchenko NA, Iakova P, Cai ZJ, Smith JR, Timchenko LT. 2001. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol. Cell. Biol. 21:6927-38
87. Timchenko NA, Patel R, Iakova P, Cai ZJ, Quan L, Timchenko LT. 2004. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J. Biol. Chem. 279:13129-39
88. Timchenko NA, Welm AL, Lu X, Timchenko LT. 1999. CUG repeat binding protein (CUGBP1) interacts with the 5′ region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. Nucleic Acids Res. 27:4517-25
89. Topisirovic I, Dragasevic N, Savic D, Ristic A, Keckarevic M, et al. 2002. Genetic and clinical analysis of spinocerebellar ataxia type 8 repeat expansion in Yugoslavia. Clin. Genet. 62:321-24
90. Van Dam D, Errijgers V, Kooy RF, Willemsen R, Mientjes E, et al. 2005. Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS). Behav. Brain Res. 162:233-39
91. Willemsen R, Hoogeveen-Westerveld M, Reis S, Holstege J, Severijnen LA, et al. 2003. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum. Mol. Genet. 12:949-59